Strategic Industry Position Pregistry operates within the pharmaceutical manufacturing industry with a specialized focus on pregnancy-related drug and vaccine safety, positioning it as a key partner for pharma companies seeking expert solutions in reproductive health safety compliance.

Recent Acquisition Growth As part of CorEvitas since March 2023, Pregistry benefits from expanded resources and market reach, presenting opportunities for cross-selling comprehensive patient registry and real-world evidence services to pharmaceutical clients.

Expert Leadership The appointment of a Chief Medical Officer in 2022 highlights Pregistry’s commitment to clinical excellence, making it an attractive partner for companies seeking credible, scientifically supported data and research collaborations in pregnancy health.

Recognized Market Presence Winning the 2019 Healthcare & Pharmaceutical Award for best pregnancy information platform enhances its credibility, providing leverage for sales pitches to healthcare and pharma organizations prioritizing trusted maternal health data solutions.

Technology and Data Focus With a robust tech stack supporting its registry and research functions, Pregistry offers scalable, data-driven solutions that can be tailored to meet the increasing demand for real-world evidence and regulatory compliance in pharmaceutical development.